These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32526214)

  • 21. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.
    Naqvi K; Sasaki K; Montalban-Bravo G; Alfonso Pierola A; Yilmaz M; Short N; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Kanagal-Shamanna R; Patel K; Soltysiak KA; Kantarjian HM; Garcia-Manero G
    Cancer; 2019 Jul; 125(13):2233-2241. PubMed ID: 30861111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in Hematopoiesis.
    Jeong JJ; Gu X; Nie J; Sundaravel S; Liu H; Kuo WL; Bhagat TD; Pradhan K; Cao J; Nischal S; McGraw KL; Bhattacharyya S; Bishop MR; Artz A; Thirman MJ; Moliterno A; Ji P; Levine RL; Godley LA; Steidl U; Bieker JJ; List AF; Saunthararajah Y; He C; Verma A; Wickrema A
    Cancer Discov; 2019 Jun; 9(6):778-795. PubMed ID: 30944118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
    Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
    JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Saliva-derived DNA is suitable for the detection of clonal haematopoiesis of indeterminate potential.
    O'Reilly RL; Burke J; Harraka P; Yeh P; Howlett K; Behrouzfar K; Rewse A; Tsimiklis H; Giles GG; Bubb KJ; Nicholls SJ; Milne RL; Southey MC
    Sci Rep; 2024 Aug; 14(1):18917. PubMed ID: 39143154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited causes of clonal haematopoiesis in 97,691 whole genomes.
    Bick AG; Weinstock JS; Nandakumar SK; Fulco CP; Bao EL; Zekavat SM; Szeto MD; Liao X; Leventhal MJ; Nasser J; Chang K; Laurie C; Burugula BB; Gibson CJ; Lin AE; Taub MA; Aguet F; Ardlie K; Mitchell BD; Barnes KC; Moscati A; Fornage M; Redline S; Psaty BM; Silverman EK; Weiss ST; Palmer ND; Vasan RS; Burchard EG; Kardia SLR; He J; Kaplan RC; Smith NL; Arnett DK; Schwartz DA; Correa A; de Andrade M; Guo X; Konkle BA; Custer B; Peralta JM; Gui H; Meyers DA; McGarvey ST; Chen IY; Shoemaker MB; Peyser PA; Broome JG; Gogarten SM; Wang FF; Wong Q; Montasser ME; Daya M; Kenny EE; North KE; Launer LJ; Cade BE; Bis JC; Cho MH; Lasky-Su J; Bowden DW; Cupples LA; Mak ACY; Becker LC; Smith JA; Kelly TN; Aslibekyan S; Heckbert SR; Tiwari HK; Yang IV; Heit JA; Lubitz SA; Johnsen JM; Curran JE; Wenzel SE; Weeks DE; Rao DC; Darbar D; Moon JY; Tracy RP; Buth EJ; Rafaels N; Loos RJF; Durda P; Liu Y; Hou L; Lee J; Kachroo P; Freedman BI; Levy D; Bielak LF; Hixson JE; Floyd JS; Whitsel EA; Ellinor PT; Irvin MR; Fingerlin TE; Raffield LM; Armasu SM; Wheeler MM; Sabino EC; Blangero J; Williams LK; Levy BD; Sheu WH; Roden DM; Boerwinkle E; Manson JE; Mathias RA; Desai P; Taylor KD; Johnson AD; ; Auer PL; Kooperberg C; Laurie CC; Blackwell TW; Smith AV; Zhao H; Lange E; Lange L; Rich SS; Rotter JI; Wilson JG; Scheet P; Kitzman JO; Lander ES; Engreitz JM; Ebert BL; Reiner AP; Jaiswal S; Abecasis G; Sankaran VG; Kathiresan S; Natarajan P
    Nature; 2020 Oct; 586(7831):763-768. PubMed ID: 33057201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
    Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K
    Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
    Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
    J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.
    Marnell CS; Bick A; Natarajan P
    J Mol Cell Cardiol; 2021 Dec; 161():98-105. PubMed ID: 34298011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):264-269. PubMed ID: 30504320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.
    López-Moyado IF; Tsagaratou A; Yuita H; Seo H; Delatte B; Heinz S; Benner C; Rao A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16933-16942. PubMed ID: 31371502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent Effects of Dnmt3a and Tet2 Mutations on Hematopoietic Progenitor Cell Fitness.
    Ostrander EL; Kramer AC; Mallaney C; Celik H; Koh WK; Fairchild J; Haussler E; Zhang CRC; Challen GA
    Stem Cell Reports; 2020 Apr; 14(4):551-560. PubMed ID: 32220332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-Associated
    Ferrone CK; Blydt-Hansen M; Rauh MJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.
    Vainchenker W; Kralovics R
    Blood; 2017 Feb; 129(6):667-679. PubMed ID: 28028029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lineage restriction analyses in CHIP indicate myeloid bias for
    Buscarlet M; Provost S; Zada YF; Bourgoin V; Mollica L; Dubé MP; Busque L
    Blood; 2018 Jul; 132(3):277-280. PubMed ID: 29764839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHIPing away at immunity: the role of clonal hematopoiesis of indeterminate potential in bacterial pneumonia.
    Bou Ghanem EN
    J Clin Invest; 2024 Jun; 134(11):. PubMed ID: 38828722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic dysregulation of hematopoietic stem cells and preleukemic state.
    Kunimoto H; Nakajima H
    Int J Hematol; 2017 Jul; 106(1):34-44. PubMed ID: 28555413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.